214 related articles for article (PubMed ID: 17012295)
1. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.
Masters CL; Beyreuther K
Brain; 2006 Nov; 129(Pt 11):2823-39. PubMed ID: 17012295
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic approaches to Alzheimer's disease.
Klafki HW; Staufenbiel M; Kornhuber J; Wiltfang J
Brain; 2006 Nov; 129(Pt 11):2840-55. PubMed ID: 17018549
[TBL] [Abstract][Full Text] [Related]
3. beta-amyloid: friend or foe.
Campbell A
Med Hypotheses; 2001 Mar; 56(3):388-91. PubMed ID: 11359367
[TBL] [Abstract][Full Text] [Related]
4. [Physiopathology of dementia of the Alzheimer type: role of the amyloid beta-protein].
Lamour Y
Ann Med Psychol (Paris); 1992; 150(2-3):131-7. PubMed ID: 1343507
[TBL] [Abstract][Full Text] [Related]
5. The APP family of proteins: similarities and differences.
Walsh DM; Minogue AM; Sala Frigerio C; Fadeeva JV; Wasco W; Selkoe DJ
Biochem Soc Trans; 2007 Apr; 35(Pt 2):416-20. PubMed ID: 17371289
[TBL] [Abstract][Full Text] [Related]
6. Intracellular amyloid-beta in Alzheimer's disease.
LaFerla FM; Green KN; Oddo S
Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease therapeutics: new approaches to an ageing problem.
Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI
IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347
[TBL] [Abstract][Full Text] [Related]
8. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
9. The development of amyloid beta protein deposits in the aged brain.
Thal DR; Capetillo-Zarate E; Del Tredici K; Braak H
Sci Aging Knowledge Environ; 2006 Mar; 2006(6):re1. PubMed ID: 16525193
[TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
11. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.
Marcello E; Epis R; Di Luca M
Eur J Pharmacol; 2008 May; 585(1):109-18. PubMed ID: 18377893
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
14. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
[TBL] [Abstract][Full Text] [Related]
15. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
16. Neuropathologic changes in Alzheimer's disease.
Wenk GL
J Clin Psychiatry; 2003; 64 Suppl 9():7-10. PubMed ID: 12934968
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology.
Silvestrelli G; Lanari A; Parnetti L; Tomassoni D; Amenta F
Mech Ageing Dev; 2006 Feb; 127(2):148-57. PubMed ID: 16278007
[TBL] [Abstract][Full Text] [Related]
18. [Research progress on Alzheimer's disease: pathogenesis and medical therapy].
Sheng SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):101-3. PubMed ID: 15171541
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta aggregation.
Finder VH; Glockshuber R
Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
